Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Acute Kidney Injury | Research

Acute kidney injury in hospitalized patients with nonmalignant pleural effusions: a retrospective cohort study

Authors: Danni Wang, Yue Niu, Dinghua Chen, Chaofan Li, Fei Liu, Zhe Feng, Xueying Cao, Li Zhang, Guangyan Cai, Xiangmei Chen, Ping Li

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Nonmalignant pleural effusion (NMPE) is common and remains a definite health care problem. Pleural effusion was supposed to be a risk factor for acute kidney injury (AKI). Incidence of AKI in NMPE patients and whether there is correlation between the size of effusions and AKI is unknown.

Objective

To assess the incidence of AKI in NMPE inpatients and its association with effusion size.

Study design and method

We conducted a retrospective cohort study of inpatients admitted to the Chinese PLA General Hospital with pleural effusion from 2018-2021. All patients with pleural effusions confirmed by chest radiography (CT or X-ray) were included, excluding patients with diagnosis of malignancy, chronic dialysis, end-stage renal disease (ESRD), community-acquired AKI, hospital-acquired AKI before chest radiography, and fewer than two serum creatinine tests during hospitalization. Multivariate logistic regression and LASSO logistic regression models were used to identify risk factors associated with AKI. Subgroup analyses and interaction tests for effusion volume were performed adjusted for the variables selected by LASSO. Causal mediation analysis was used to estimate the mediating effect of heart failure, pneumonia, and eGFR < 60 ml/min/1.73m2 on AKI through effusion volume.

Results

NMPE was present in 7.8% of internal medicine inpatients. Of the 3047 patients included, 360 (11.8%) developed AKI during hospitalization. After adjustment by covariates selected by LASSO, moderate and large effusions increased the risk of AKI compared with small effusions (moderate: OR 1.47, 95%CI 1.11-1.94 p = 0.006; large: OR 1.86, 95%CI 1.05-3.20 p = 0.028). No significant modification effect was observed among age, gender, diabetes, bilateral effusions, and eGFR. Volume of effusions mediated 6.8% (p = 0.005), 4.0% (p = 0.046) and 4.6% (p < 0.001) of the effect of heart failure, pneumonia and low eGFR on the development of AKI respectively.

Conclusion

The incidence of AKI is high among NMPE patients. Moderate and large effusion volume is independently associated with AKI compared to small size. The effusion size acts as a mediator in heart failure, pneumonia, and eGFR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Grendelmeier P, Rahman NM. What’s the score? Do pleural effusion clinical scoring systems help in management of disease? Semin Respir Crit Care Med. 2019;40(3):394–401.PubMedCrossRef Grendelmeier P, Rahman NM. What’s the score? Do pleural effusion clinical scoring systems help in management of disease? Semin Respir Crit Care Med. 2019;40(3):394–401.PubMedCrossRef
2.
go back to reference Porcel JM. Nonmalignant pleural effusions. Seminars Respir Crit Care Med. 2022;43(4):570–82.CrossRef Porcel JM. Nonmalignant pleural effusions. Seminars Respir Crit Care Med. 2022;43(4):570–82.CrossRef
5.
go back to reference Doyle JF, Forni LG. Acute kidney injury: short-term and long-term effects. Critical care (London, England). 2016;20(1):188.PubMedCrossRef Doyle JF, Forni LG. Acute kidney injury: short-term and long-term effects. Critical care (London, England). 2016;20(1):188.PubMedCrossRef
6.
go back to reference Xu X, Nie S, Liu Z, Chen C, Xu G, Zha Y, Qian J, Liu B, Han S, Xu A, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults. Clin J Am Soc Nephrol. 2015;10(9):1510–8.PubMedPubMedCentralCrossRef Xu X, Nie S, Liu Z, Chen C, Xu G, Zha Y, Qian J, Liu B, Han S, Xu A, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults. Clin J Am Soc Nephrol. 2015;10(9):1510–8.PubMedPubMedCentralCrossRef
7.
go back to reference O’Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104(7):868–76.PubMedCrossRef O’Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104(7):868–76.PubMedCrossRef
8.
go back to reference Uchino S, Bellomo R, Bagshaw SM, Goldsmith D. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol, Dialy, Transplant. 2010;25(6):1833–9.CrossRef Uchino S, Bellomo R, Bagshaw SM, Goldsmith D. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol, Dialy, Transplant. 2010;25(6):1833–9.CrossRef
9.
go back to reference Razazi K, Thille AW, Carteaux G, Beji O, Brun-Buisson C, Brochard L, Mekontso Dessap A. Effects of pleural effusion drainage on oxygenation, respiratory mechanics, and hemodynamics in mechanically ventilated patients. Ann Am Thorac Soc. 2014;11(7):1018–24.PubMedCrossRef Razazi K, Thille AW, Carteaux G, Beji O, Brun-Buisson C, Brochard L, Mekontso Dessap A. Effects of pleural effusion drainage on oxygenation, respiratory mechanics, and hemodynamics in mechanically ventilated patients. Ann Am Thorac Soc. 2014;11(7):1018–24.PubMedCrossRef
10.
go back to reference Wang Z, Cai QZ, Ban CJ, Chen D, Xu LL, Wang XJ, Wang Z, Yang Y, Lv XZ, Shi HZ. Improved heart hemodynamics after draining large-volume pleural effusion: a prospective cohort study. BMC Pulm Med. 2018;18(1):62.PubMedPubMedCentralCrossRef Wang Z, Cai QZ, Ban CJ, Chen D, Xu LL, Wang XJ, Wang Z, Yang Y, Lv XZ, Shi HZ. Improved heart hemodynamics after draining large-volume pleural effusion: a prospective cohort study. BMC Pulm Med. 2018;18(1):62.PubMedPubMedCentralCrossRef
11.
go back to reference Siniorakis EE, Arapi SM, Kaplanis IK, Tzevelekos PV, Aivalioti FG, Pyrgakis VN, Limberi SJ. Acute renal injury in the course of a large pleural effusion. J Clin Anesth. 2017;38:31–2.PubMedCrossRef Siniorakis EE, Arapi SM, Kaplanis IK, Tzevelekos PV, Aivalioti FG, Pyrgakis VN, Limberi SJ. Acute renal injury in the course of a large pleural effusion. J Clin Anesth. 2017;38:31–2.PubMedCrossRef
12.
go back to reference Li P, Xie C, Pollard T, Johnson AEW, Cao D, Kang H, Liang H, Zhang Y, Liu X, Fan Y, et al. Promoting secondary analysis of electronic medical records in China: summary of the PLAGH-MIT critical data conference and health datathon. JMIR Med Inform. 2017;5(4): e43.PubMedPubMedCentralCrossRef Li P, Xie C, Pollard T, Johnson AEW, Cao D, Kang H, Liang H, Zhang Y, Liu X, Fan Y, et al. Promoting secondary analysis of electronic medical records in China: summary of the PLAGH-MIT critical data conference and health datathon. JMIR Med Inform. 2017;5(4): e43.PubMedPubMedCentralCrossRef
13.
go back to reference Markatis E, Perlepe G, Afthinos A, Pagkratis K, Varsamas C, Chaini E, Papanikolaou IC, Gourgoulianis KI. Mortality among hospitalized patients with pleural effusions. A multicenter, observational prospect study. Front Med. 2022;9:828783.CrossRef Markatis E, Perlepe G, Afthinos A, Pagkratis K, Varsamas C, Chaini E, Papanikolaou IC, Gourgoulianis KI. Mortality among hospitalized patients with pleural effusions. A multicenter, observational prospect study. Front Med. 2022;9:828783.CrossRef
14.
go back to reference Martínez-Moragón E, Aparicio J, Sanchis J, Menéndez R, Cruz Rogado M, Sanchis F. Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respir Intern Rev Thor Dis. 1998;65(2):108–13. Martínez-Moragón E, Aparicio J, Sanchis J, Menéndez R, Cruz Rogado M, Sanchis F. Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respir Intern Rev Thor Dis. 1998;65(2):108–13.
15.
go back to reference Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC, Stevens PE. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021;100(3):516–26.PubMedCrossRef Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC, Stevens PE. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021;100(3):516–26.PubMedCrossRef
16.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.PubMedPubMedCentralCrossRef Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.PubMedPubMedCentralCrossRef
17.
go back to reference Pavlou M, Ambler G, Seaman SR, Guttmann O, Elliott P, King M, Omar RZ. How to develop a more accurate risk prediction model when there are few events. BMJ (Clinical Research ed). 2015;351: h3868.PubMed Pavlou M, Ambler G, Seaman SR, Guttmann O, Elliott P, King M, Omar RZ. How to develop a more accurate risk prediction model when there are few events. BMJ (Clinical Research ed). 2015;351: h3868.PubMed
18.
go back to reference Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. Psychol Methods. 2010;15(4):309–34.PubMedCrossRef Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. Psychol Methods. 2010;15(4):309–34.PubMedCrossRef
19.
go back to reference DeBiasi E, Puchalski J. Pleural effusions as markers of mortality and disease severity: a state-of-the-art review. Curr Opin Pulm Med. 2016;22(4):386–91.PubMedCrossRef DeBiasi E, Puchalski J. Pleural effusions as markers of mortality and disease severity: a state-of-the-art review. Curr Opin Pulm Med. 2016;22(4):386–91.PubMedCrossRef
20.
go back to reference Wemmelund KB, Lie RH, Juhl-Olsen P, Frederiksen CA, Hermansen JF, Sloth E. Pleural effusion decreases left ventricular pre-load and causes haemodynamic compromise: an experimental porcine study. Acta Anaesthesiol Scand. 2012;56(7):833–9.PubMedCrossRef Wemmelund KB, Lie RH, Juhl-Olsen P, Frederiksen CA, Hermansen JF, Sloth E. Pleural effusion decreases left ventricular pre-load and causes haemodynamic compromise: an experimental porcine study. Acta Anaesthesiol Scand. 2012;56(7):833–9.PubMedCrossRef
21.
go back to reference Nishida O, Arellano R, Cheng DC, DeMajo W, Kavanagh BP. Gas exchange and hemodynamics in experimental pleural effusion. Crit Care Med. 1999;27(3):583–7.PubMedCrossRef Nishida O, Arellano R, Cheng DC, DeMajo W, Kavanagh BP. Gas exchange and hemodynamics in experimental pleural effusion. Crit Care Med. 1999;27(3):583–7.PubMedCrossRef
22.
go back to reference Montero Ruiz E, Hernández Ahijado C, García Sánchez F, López Alvarez J. Effects of pleural effusion. Anales De Medicina Interna (Madrid, Spain : 1984). 2006;23(8):389–92.PubMed Montero Ruiz E, Hernández Ahijado C, García Sánchez F, López Alvarez J. Effects of pleural effusion. Anales De Medicina Interna (Madrid, Spain : 1984). 2006;23(8):389–92.PubMed
23.
go back to reference Degirmenci NA, Metintas M, Atlanoglu S, Yildirim H. Evaluation of the renal resistive index and pulsatility index in patients with pleural effusion by duplex Doppler ultrasonography. Jpn J Radiol. 2013;31(1):39–44.PubMedCrossRef Degirmenci NA, Metintas M, Atlanoglu S, Yildirim H. Evaluation of the renal resistive index and pulsatility index in patients with pleural effusion by duplex Doppler ultrasonography. Jpn J Radiol. 2013;31(1):39–44.PubMedCrossRef
24.
go back to reference Singh VK, Wu BU, Bollen TL, Repas K, Maurer R, Johannes RS, Mortele KJ, Conwell DL, Banks PA. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol. 2009;104(4):966–71.PubMedCrossRef Singh VK, Wu BU, Bollen TL, Repas K, Maurer R, Johannes RS, Mortele KJ, Conwell DL, Banks PA. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol. 2009;104(4):966–71.PubMedCrossRef
25.
go back to reference Song Y, Sun W, Dai D, Liu Y, Li Z, Tian Z, Liu X. Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia. Expert Rev Respir Med. 2021;15(5):689–96.PubMedCrossRef Song Y, Sun W, Dai D, Liu Y, Li Z, Tian Z, Liu X. Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia. Expert Rev Respir Med. 2021;15(5):689–96.PubMedCrossRef
26.
go back to reference Chung CL, Hsiao SH, Hsiao G, Sheu JR, Chen WL, Chang SC. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions. Plos One. 2013;8(1):e53169.PubMedPubMedCentralCrossRef Chung CL, Hsiao SH, Hsiao G, Sheu JR, Chen WL, Chang SC. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions. Plos One. 2013;8(1):e53169.PubMedPubMedCentralCrossRef
27.
go back to reference Yan G, Li H, Bhetuwal A, McClure MA, Li Y, Yang G, Li Y, Zhao L, Fan X. Pleural effusion volume in patients with acute pancreatitis: a retrospective study from three acute pancreatitis centers. Ann Med. 2021;53(1):2003–18.PubMedCrossRef Yan G, Li H, Bhetuwal A, McClure MA, Li Y, Yang G, Li Y, Zhao L, Fan X. Pleural effusion volume in patients with acute pancreatitis: a retrospective study from three acute pancreatitis centers. Ann Med. 2021;53(1):2003–18.PubMedCrossRef
28.
go back to reference Li WX, Xu W, Huang CL, Fei L, Xie XD, Li Q, Chen L. Acute cardiac injury and acute kidney injury associated with severity and mortality in patients with COVID-19. Eur Rev Med Pharmacol Sci. 2021;25(4):2114–22.PubMed Li WX, Xu W, Huang CL, Fei L, Xie XD, Li Q, Chen L. Acute cardiac injury and acute kidney injury associated with severity and mortality in patients with COVID-19. Eur Rev Med Pharmacol Sci. 2021;25(4):2114–22.PubMed
29.
go back to reference Khanna S, Keddis MT, Noheria A, Baddour LM, Pardi DS. Acute kidney injury is an independent marker of severity in Clostridium difficile infection: a nationwide survey. J Clin Gastroenterol. 2013;47(6):481–4.PubMedCrossRef Khanna S, Keddis MT, Noheria A, Baddour LM, Pardi DS. Acute kidney injury is an independent marker of severity in Clostridium difficile infection: a nationwide survey. J Clin Gastroenterol. 2013;47(6):481–4.PubMedCrossRef
30.
go back to reference White LE, Hassoun HT, Bihorac A, Moore LJ, Sailors RM, McKinley BA, Valdivia A, Moore FA. Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis. J Trauma Acute Care Surg. 2013;75(3):432–8.PubMedCrossRef White LE, Hassoun HT, Bihorac A, Moore LJ, Sailors RM, McKinley BA, Valdivia A, Moore FA. Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis. J Trauma Acute Care Surg. 2013;75(3):432–8.PubMedCrossRef
31.
go back to reference Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, Naimark D, Oien C, Smith DH, Coresh J, et al. A Meta-analysis of the association of estimated GFR, Albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis. 2015;66(4):591–601.PubMedPubMedCentralCrossRef Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, Naimark D, Oien C, Smith DH, Coresh J, et al. A Meta-analysis of the association of estimated GFR, Albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis. 2015;66(4):591–601.PubMedPubMedCentralCrossRef
32.
go back to reference Wu H, Huang J. Drug-induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies. Curr Drug Metab. 2018;19(7):559–67.PubMedCrossRef Wu H, Huang J. Drug-induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies. Curr Drug Metab. 2018;19(7):559–67.PubMedCrossRef
33.
go back to reference Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EF, Silva Junior GBD. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019;41(1):124–30.PubMedCrossRef Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EF, Silva Junior GBD. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019;41(1):124–30.PubMedCrossRef
34.
go back to reference Amitai I, Rozovski U, El-Saleh R, Shimony S, Shepshelovich D, Rozen-Zvi B, Raanani P, Gafter-Gvili A, Gurion R. Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies. Hematol Oncol. 2020;38(4):584–8.PubMedCrossRef Amitai I, Rozovski U, El-Saleh R, Shimony S, Shepshelovich D, Rozen-Zvi B, Raanani P, Gafter-Gvili A, Gurion R. Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies. Hematol Oncol. 2020;38(4):584–8.PubMedCrossRef
35.
go back to reference Singh J, Malik P, Patel N, Pothuru S, Israni A, Chakinala RC, Hussain MR, Chidharla A, Patel H, Patel SK, et al. Kidney disease and COVID-19 disease severity-systematic review and meta-analysis. Clin Exp Med. 2022;22(1):125–35.PubMedCrossRef Singh J, Malik P, Patel N, Pothuru S, Israni A, Chakinala RC, Hussain MR, Chidharla A, Patel H, Patel SK, et al. Kidney disease and COVID-19 disease severity-systematic review and meta-analysis. Clin Exp Med. 2022;22(1):125–35.PubMedCrossRef
36.
go back to reference Yang CW, Li S, Dong Y, Paliwal N, Wang Y. Epidemiology and the Impact of Acute Kidney Injury on Outcomes in Patients with Rhabdomyolysis. J Clin Med. 2021;10(9):1950.PubMedPubMedCentralCrossRef Yang CW, Li S, Dong Y, Paliwal N, Wang Y. Epidemiology and the Impact of Acute Kidney Injury on Outcomes in Patients with Rhabdomyolysis. J Clin Med. 2021;10(9):1950.PubMedPubMedCentralCrossRef
37.
go back to reference DeBiasi EM, Pisani MA, Murphy TE, Araujo K, Kookoolis A, Argento AC, Puchalski J. Mortality among patients with pleural effusion undergoing thoracentesis. Eur Respir J. 2015;46(2):495–502.PubMedPubMedCentralCrossRef DeBiasi EM, Pisani MA, Murphy TE, Araujo K, Kookoolis A, Argento AC, Puchalski J. Mortality among patients with pleural effusion undergoing thoracentesis. Eur Respir J. 2015;46(2):495–502.PubMedPubMedCentralCrossRef
38.
go back to reference Marchi E, Vargas FS, Acencio MM, Sigrist RMS, Biscaro MDA, Antonangelo L, Teixeira LR, Light RW. Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions. Chest. 2012;141(1):183–9.PubMedCrossRef Marchi E, Vargas FS, Acencio MM, Sigrist RMS, Biscaro MDA, Antonangelo L, Teixeira LR, Light RW. Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions. Chest. 2012;141(1):183–9.PubMedCrossRef
39.
go back to reference Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518–26.PubMedCrossRef Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518–26.PubMedCrossRef
40.
go back to reference Roelofs JJ, Rouschop KM, Leemans JC, Claessen N, de Boer AM, Frederiks WM, Lijnen HR, Weening JJ, Florquin S. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol. 2006;17(1):131–40.PubMedCrossRef Roelofs JJ, Rouschop KM, Leemans JC, Claessen N, de Boer AM, Frederiks WM, Lijnen HR, Weening JJ, Florquin S. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol. 2006;17(1):131–40.PubMedCrossRef
41.
go back to reference Wlodzimirow KA, Abu-Hanna A, Slabbekoorn M, Chamuleau RA, Schultz MJ, Bouman CS. A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ill patients. Crit Care (London, England). 2012;16(5):R200.CrossRef Wlodzimirow KA, Abu-Hanna A, Slabbekoorn M, Chamuleau RA, Schultz MJ, Bouman CS. A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ill patients. Crit Care (London, England). 2012;16(5):R200.CrossRef
42.
go back to reference Tzeng IS. To handle the inflation of odds ratios in a retrospective study with a profile penalized log-likelihood approach. J Clin Lab Anal. 2021;35(7):e23849.PubMedPubMedCentralCrossRef Tzeng IS. To handle the inflation of odds ratios in a retrospective study with a profile penalized log-likelihood approach. J Clin Lab Anal. 2021;35(7):e23849.PubMedPubMedCentralCrossRef
Metadata
Title
Acute kidney injury in hospitalized patients with nonmalignant pleural effusions: a retrospective cohort study
Authors
Danni Wang
Yue Niu
Dinghua Chen
Chaofan Li
Fei Liu
Zhe Feng
Xueying Cao
Li Zhang
Guangyan Cai
Xiangmei Chen
Ping Li
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03556-4

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.